CytoDyn Inc.
CYDY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001175680
No open-market purchases or sales by CytoDyn Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $35.2K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding CytoDyn Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 20 | 16 | −4 |
| Shares | 837.9K | 606.9K | −231.0K (−27.6%) |
| Value | $1.43M | $1.21M | −$220.0K (−15.4%) |
New holders (1)
Institutions that held CytoDyn Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Next Capital Management LLC | 37,500 | $74.0K | 0.05% |
Sold out (5)
Institutions that held CytoDyn Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Fairfield, Bush & Co. | 155,109 | $264.0K |
| Willis Investment Counsel | 87,237 | $148.0K |
| McCarthy Asset Management, Inc. | 4,300 | $7.00K |
| Tradition Wealth Management, LLC | 2,697 | $5.00K |
| Dividend Assets Capital, LLC | 50 | $0 |